Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Cheymol, G
   Effects of obesity on pharmacokinetics - Implications for drug therapy
   CLINICAL PHARMACOKINETICS
   
   G. Cheymol, "Effects of obesity on pharmacokinetics - Implications for drug therapy", CLIN PHARMA, 39(3), 2000, pp. 215-231
2. Weissenburger, J; Noyer, M; Cheymol, G; Jaillon, P
   Electrophysiological effects of cetirizine, astemizole and D-sotalol in a canine model of long QT syndrome
   CLINICAL AND EXPERIMENTAL ALLERGY
   
   J. Weissenburger et al., "Electrophysiological effects of cetirizine, astemizole and D-sotalol in a canine model of long QT syndrome", CLIN EXP AL, 29, 1999, pp. 190-196
3. Cheymol, G; Poirier, JM
   Use of itraconazole as prophylaxis of systemic aspergillosis in neutropenic patients : interest of drug monitoring
   BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE
   
   G. Cheymol e J.M. Poirier, "Use of itraconazole as prophylaxis of systemic aspergillosis in neutropenic patients : interest of drug monitoring", B ACA N MED, 183(2), 1999, pp. 371-381
4. CHEZALVIELGUILBERT F; DEPLANNE V; DAVY JM; POIRIER JM; XIA YZ; CHEYMOL G; WEISSENBURGER J
   COMBINATION OF SOTALOL AND QUINIDINE IN A CANINE MODEL OF TORSADES-DE-POINTES - NO INCREASE IN THE QT-RELATED PROARRHYTHMIC ACTION OF SOTALOL
   Journal of cardiovascular electrophysiology
   
   F. Chezalvielguilbert et al., "COMBINATION OF SOTALOL AND QUINIDINE IN A CANINE MODEL OF TORSADES-DE-POINTES - NO INCREASE IN THE QT-RELATED PROARRHYTHMIC ACTION OF SOTALOL", Journal of cardiovascular electrophysiology, 9(5), 1998, pp. 498-507
5. Poirier, JM; Cheymol, G
   Optimisation of itraconazole therapy using target drug concentrations
   CLINICAL PHARMACOKINETICS
   
   J.M. Poirier e G. Cheymol, "Optimisation of itraconazole therapy using target drug concentrations", CLIN PHARMA, 35(6), 1998, pp. 461-473
6. Cheymol, G; Poirier, JM
   Recent data on monitoring serum levels of aminoglycosides and vancomycin.
   SEMAINE DES HOPITAUX
   
   G. Cheymol e J.M. Poirier, "Recent data on monitoring serum levels of aminoglycosides and vancomycin.", SEM HOP PAR, 74(35-36), 1998, pp. 1307-1313
7. CHEYMOL G; POIRIER JM
   RECENT ASPECTS OF MONITORING THERAPY WITH AMINOGLYCOSIDES AND VANCOMYCIN
   Bulletin de l'Academie nationale de medecine
   
   G. Cheymol e J.M. Poirier, "RECENT ASPECTS OF MONITORING THERAPY WITH AMINOGLYCOSIDES AND VANCOMYCIN", Bulletin de l'Academie nationale de medecine, 182(2), 1998, pp. 285-298
8. CHEYMOL G; POIRIER JM; CARRUPT PA; TESTA B; WEISSENBURGER J; LEVRON JC; SNOECK E
   PHARMACOKINETICS OF BETA-ADRENOCEPTOR BLOCKERS IN OBESE AND NORMAL VOLUNTEERS
   British journal of clinical pharmacology
   
   G. Cheymol et al., "PHARMACOKINETICS OF BETA-ADRENOCEPTOR BLOCKERS IN OBESE AND NORMAL VOLUNTEERS", British journal of clinical pharmacology, 43(6), 1997, pp. 563-570
9. POIRIER JM; HARDY S; ISNARD F; TILLEUL P; WEISSENBURGER J; CHEYMOL G
   PLASMA ITRACONAZOLE CONCENTRATIONS IN PATIENTS WITH NEUTROPENIA - ADVANTAGES OF A DIVIDED DAILY DOSAGE REGIMEN
   Therapeutic drug monitoring
   
   J.M. Poirier et al., "PLASMA ITRACONAZOLE CONCENTRATIONS IN PATIENTS WITH NEUTROPENIA - ADVANTAGES OF A DIVIDED DAILY DOSAGE REGIMEN", Therapeutic drug monitoring, 19(5), 1997, pp. 525-529
10. POIRIER JM; CHEYMOL G
    A RAPID AND SPECIFIC LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF ITRACONAZOLE AND HYDROXYITRACONAZOLE IN PLASMA
    Therapeutic drug monitoring
    
    J.M. Poirier e G. Cheymol, "A RAPID AND SPECIFIC LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF ITRACONAZOLE AND HYDROXYITRACONAZOLE IN PLASMA", Therapeutic drug monitoring, 19(2), 1997, pp. 247-248
11. LIBERSA C; CHEYMOL G
    JOINT MEETING OF THE FRENCH-SOCIETY-OF-CL INICAL-PHARMACOLOGY-AND-THERAPEUTICS AND OF THE WORKSHOP OF CLINICAL-PHARMACOLOGY AND THERAPEUTICS OF THE FRENCH-SOCIETY-OF-CARDIOLOGY - PARIS, 10-MAY-1996
    Therapie
    
    C. Libersa e G. Cheymol, "JOINT MEETING OF THE FRENCH-SOCIETY-OF-CL INICAL-PHARMACOLOGY-AND-THERAPEUTICS AND OF THE WORKSHOP OF CLINICAL-PHARMACOLOGY AND THERAPEUTICS OF THE FRENCH-SOCIETY-OF-CARDIOLOGY - PARIS, 10-MAY-1996", Therapie, 52(1), 1997, pp. 5-5
12. CHEYMOL G; WOESTENBORGHS R; SNOECK E; IANUCCI R; LEMOING JP; NADITCH L; LEVRON JC; POIRIER JM
    PHARMACOKINETIC STUDY AND CARDIOVASCULAR MONITORING OF NEBIVOLOL IN NORMAL AND OBESE SUBJECTS
    European Journal of Clinical Pharmacology
    
    G. Cheymol et al., "PHARMACOKINETIC STUDY AND CARDIOVASCULAR MONITORING OF NEBIVOLOL IN NORMAL AND OBESE SUBJECTS", European Journal of Clinical Pharmacology, 51(6), 1997, pp. 493-498
13. BIOUR M; POUPON R; GRANGE JD; CHAZOUILLERES O; LEVY VG; BODIN F; CHEYMOL G
    DRUG-INDUCED LIVER-INJURY - 9TH UPDATED E DITION OF THE BIBLIOGRAPHICDATABASE OF LIVER INJURIES AND RELATED DRUGS
    Gastroenterologie clinique et biologique
    
    M. Biour et al., "DRUG-INDUCED LIVER-INJURY - 9TH UPDATED E DITION OF THE BIBLIOGRAPHICDATABASE OF LIVER INJURIES AND RELATED DRUGS", Gastroenterologie clinique et biologique, 20(10), 1996, pp. 744-779
14. CHEYMOL G; BECHTEL P
    LE-1ER-CONGRES-DE-LEUROPEAN-ASSOCIATION-F OR-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS - THE FIRST CONGRESS OF EACPT IN PARIS, SEPTEMBER 27-30, 1995
    Therapie
    
    G. Cheymol e P. Bechtel, "LE-1ER-CONGRES-DE-LEUROPEAN-ASSOCIATION-F OR-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS - THE FIRST CONGRESS OF EACPT IN PARIS, SEPTEMBER 27-30, 1995", Therapie, 51(4), 1996, pp. 335-336
15. POIRIER JM; BERLIOZ F; ISNARD F; CHEYMOL G
    MARKED INTRA-PATIENT AND INTER-PATIENT VARIABILITY OF ITRACONAZOLE STEADY-STATE PLASMA-CONCENTRATIONS
    Therapie
    
    J.M. Poirier et al., "MARKED INTRA-PATIENT AND INTER-PATIENT VARIABILITY OF ITRACONAZOLE STEADY-STATE PLASMA-CONCENTRATIONS", Therapie, 51(2), 1996, pp. 163-167
16. CHEZALVIELGUILBERT F; WEISSENBURGER J; DAVY JM; GUHENNEC C; POIRIER JM; CHEYMOL G
    PROARRHYTHMIC EFFECTS OF A QUINIDINE ANALOG IN DOGS WITH CHRONIC A-V BLOCK
    Fundamental and clinical pharmacology
    
    F. Chezalvielguilbert et al., "PROARRHYTHMIC EFFECTS OF A QUINIDINE ANALOG IN DOGS WITH CHRONIC A-V BLOCK", Fundamental and clinical pharmacology, 9(3), 1995, pp. 240-247
17. BIOUR M; POUPON R; GRANGE JD; CHAZOUILLERES O; LEVY VG; BODIN F; CHEYMOL G
    DRUG-INDUCED LIVER-INJURY - AN UPDATED BI BLIOGRAPHIC DATA-BASE OF LIVER INJURIES AND RELATED DRUGS
    Gastroenterologie clinique et biologique
    
    M. Biour et al., "DRUG-INDUCED LIVER-INJURY - AN UPDATED BI BLIOGRAPHIC DATA-BASE OF LIVER INJURIES AND RELATED DRUGS", Gastroenterologie clinique et biologique, 19(10), 1995, pp. 756
18. CHEYMOL G; WEISSENBURGER J; POIRIER JM; GELLEE C
    THE PHARMACOKINETICS OF DEXFENFLURAMINE IN OBESE AND NONOBESE SUBJECTS
    British journal of clinical pharmacology
    
    G. Cheymol et al., "THE PHARMACOKINETICS OF DEXFENFLURAMINE IN OBESE AND NONOBESE SUBJECTS", British journal of clinical pharmacology, 39(6), 1995, pp. 684-687
19. CHEYMOL G
    THERAPIE 1946-1995 - 50 YEARS OF PUBLICAT ION
    Therapie
    
    G. Cheymol, "THERAPIE 1946-1995 - 50 YEARS OF PUBLICAT ION", Therapie, 50(4), 1995, pp. 295-299
20. CHEYMOL G; ORNE M; SJOQVIST F
    EUROPEAN JOURNAL OF CLINICAL-PHARMACOLOGY BECOMES THE OFFICIAL ORGAN OF CIATION-FOR-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS
    European Journal of Clinical Pharmacology
    
    G. Cheymol et al., "EUROPEAN JOURNAL OF CLINICAL-PHARMACOLOGY BECOMES THE OFFICIAL ORGAN OF CIATION-FOR-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS", European Journal of Clinical Pharmacology, 48(5), 1995, pp. 317-318
21. CHEYMOL G
    PRESENTATION OF THE 1ST CONGRESS OF THE OCIATION-OF-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS
    European Journal of Clinical Pharmacology
    
    G. Cheymol, "PRESENTATION OF THE 1ST CONGRESS OF THE OCIATION-OF-CLINICAL-PHARMACOLOGY-AND-THERAPEUTICS", European Journal of Clinical Pharmacology, 48(5), 1995, pp. 319-319
22. BIOUR M; POUPON R; GRANGE JD; LEVY VG; BODIN F; CHEYMOL G
    DRUG-INDUCED LIVER-INJURY - AN UPDATED BI BLIOGRAPHIC DATABASE OF LIVER INJURIES AND RELATED DRUGS
    Gastroenterologie clinique et biologique
    
    M. Biour et al., "DRUG-INDUCED LIVER-INJURY - AN UPDATED BI BLIOGRAPHIC DATABASE OF LIVER INJURIES AND RELATED DRUGS", Gastroenterologie clinique et biologique, 18(6-7), 1994, pp. 574-606
23. POIRIER JM; LEBOT M; DESCAMPS P; LEVY M; CHEYMOL G
    DETERMINATION OF ITRACONAZOLE AND ITS ACTIVE METABOLITE IN PLASMA BY COLUMN LIQUID-CHROMATOGRAPHY
    Therapeutic drug monitoring
    
    J.M. Poirier et al., "DETERMINATION OF ITRACONAZOLE AND ITS ACTIVE METABOLITE IN PLASMA BY COLUMN LIQUID-CHROMATOGRAPHY", Therapeutic drug monitoring, 16(6), 1994, pp. 596-601
24. POIRIER JM; LEBOT M; CHEYMOL G
    CYCLOSPORINE IN WHOLE-BLOOD - DRUG-MONITORING DIFFICULTIES AND PRESENTATION OF A RELIABLE NORMAL-PHASE LIQUID-CHROMATOGRAPHIC ASSAY
    Therapeutic drug monitoring
    
    J.M. Poirier et al., "CYCLOSPORINE IN WHOLE-BLOOD - DRUG-MONITORING DIFFICULTIES AND PRESENTATION OF A RELIABLE NORMAL-PHASE LIQUID-CHROMATOGRAPHIC ASSAY", Therapeutic drug monitoring, 16(4), 1994, pp. 388-394
25. BIOUR M; POUPON R; GRANGE JD; CHAZOUILLERES O; LEVY VG; BODIN F; CHEYMOL G
    DRUG-INDUCED LIVER-INJURY - AN UPDATED BI BLIOGRAPHIC DATABASE OF LIVER INJURIES AND RELATED DRUGS
    Gastroenterologie clinique et biologique
    
    M. Biour et al., "DRUG-INDUCED LIVER-INJURY - AN UPDATED BI BLIOGRAPHIC DATABASE OF LIVER INJURIES AND RELATED DRUGS", Gastroenterologie clinique et biologique, 17(5BIS), 1993, pp. 80000086-80000115
26. CHEYMOL G
    CLINICAL PHARMACOKINETICS OF DRUGS IN OBESITY - AN UPDATE
    Clinical pharmacokinetics
    
    G. Cheymol, "CLINICAL PHARMACOKINETICS OF DRUGS IN OBESITY - AN UPDATE", Clinical pharmacokinetics, 25(2), 1993, pp. 103-114
27. CHEYMOL G
    PHARMACOKINETICS AND THERAPEUTIC MONITORING OF CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS
    Annales de Gastroenterologie et d'Hepatologie
    
    G. Cheymol, "PHARMACOKINETICS AND THERAPEUTIC MONITORING OF CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS", Annales de Gastroenterologie et d'Hepatologie, 29(2), 1993, pp. 81-85
28. MASINI JP; POIRIER JM; WEISSENBURGER J; DESNAULT H; HANNOUN L; BALLADUR P; NORDLINGER B; PARC R; LIENHART A; CHEYMOL G
    STUDY OF CYCLOSPORINE-A BLOOD LEVEL DURING EARLY POST HEPATIC TRANSPLANT PERIOD
    Therapie
    
    J.P. Masini et al., "STUDY OF CYCLOSPORINE-A BLOOD LEVEL DURING EARLY POST HEPATIC TRANSPLANT PERIOD", Therapie, 48(2), 1993, pp. 163-166